Statement
14 Oct 2025
78th Session of the WHO Regional Committee for South-East Asia on primary health care and universal health coverage
On 14 October 2025 in Colombo, Sri Lanka, IFPMA delivered a statement on primary health care (PHC) and universal health coverage (UHC) at the 78th Session of the WHO Regional Committee for South-East Asia. IFPMA welcomes the agenda items on PHC and UHC. Unlocking investment in primary care is critical if we are to build...
Read more
Statement
5 Sep 2025
Statement on the publication of the 24th WHO Model List of Essential Medicines
Responding to the publication of the updated WHO Model List of Essential Medicines (EML), IFPMA Director General, Dr. David Reddy said: “The inclusion of innovative medicines on the updated EML highlights how scientific advances are transforming how we prevent, treat and cure disease, and reinforces the importance of ensuring patients everywhere can benefit from them. ...
Read more
External study
24 Jun 2025
Key access pathways and bottlenecks for medicines in LMICs
Medicines and vaccines have transformed the way we prevent, treat, and cure diseases. Bringing these to people around the world requires more than scientific breakthroughs – it demands collaboration across the entire innovation and access pathway. From discovery and development to regulatory approval, supply, procurement and local delivery, each step plays a critical role in...
Read more